Cancer Therapeutics and Biotherapeutics Market Revenue 2025 to 2034

Cancer Therapeutics and Biotherapeutics Market Revenue 2025 to 2034

Pricing Login Sign Up

Cancer Therapeutics and Biotherapeutics Market (By Application: Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, Others; By Top Selling Drugs: Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, Others; By Product Type: Chemotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, Others; By End User: Consumption (Sales), Household, Hospital; By Geography: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) – Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Report ID: 10938 | Format: Databook | Published: December 2025 | Delivery: Immediate
Download Sample     Customisation Request  

Revenue, 2025

USD 210.73 Bn

Forecast Year, 2034

USD 440.59 Bn

CAGR, 2025 - 2034

8.54%

Report Coverage

Worldwide

Published By

Saurabh Bidwai

Reviewed By

Aditi Shivarkar

Reviewed By

Aman Singh

The global cancer therapeutics and biotherapeutics market was valued at USD 210.73 billion in 2025 and is projected to reach USD 440.59 billion by 2034, driven by rising cancer prevalence, biologics adoption, and ongoing oncology innovation.

Cancer Therapeutics and Biotherapeutics Market Size Analysis

Cancer Therapeutics and Biotherapeutics Market Size By Application 2025 to 2034 (USD Billion)

Application 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Blood Cancer29.5031.5133.6535.9338.3540.9243.6446.5449.6152.87
Lung Cancer27.3929.3231.3733.5635.8938.3841.0343.8646.8750.07
Colorectal Cancer23.1824.8426.6128.5030.5232.6734.9837.4440.0642.86
Prostate Cancer21.0722.6424.3226.1328.0730.1432.3734.7537.3140.05
Breast Cancer25.2927.3129.4931.8534.3937.1340.0943.2946.7450.47
Cervical Cancer10.5411.3912.3113.3114.3915.5516.8118.1719.6421.23
Head and Neck Cancer12.6413.7715.0016.3317.7819.3721.0922.9725.0127.24
Giloblastoma8.439.2910.2311.2712.4113.6615.0416.5518.2120.03
Malignant Meningioma6.327.097.958.909.9611.1312.4313.8615.4617.22
Mesothelioma6.327.198.159.2310.4311.7713.2614.9216.7718.83
Melanoma14.7516.4318.2820.3322.6025.1127.8830.9434.3238.05
Others25.2927.9630.8934.1337.7041.6245.9450.7055.9361.68

Cancer Therapeutics and Biotherapeutics Market Size By Top Selling Drugs 2025 to 2034 (USD Billion)

Top Selling Drugs 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Revlimid19.7620.9122.1223.3924.7126.0927.5229.0030.5432.13
Avastin17.5618.6019.6920.8322.0323.2724.5725.9127.3128.76
Herceptin15.3716.2917.2618.2819.3420.4521.6122.8324.0925.40
Rituxan15.3716.3617.4118.5319.7020.9422.2523.6325.0926.62
Opdivo19.7621.2022.7424.3926.1628.0530.0732.2334.5537.02
Gleevec10.9811.7412.5513.4114.3315.3116.3517.4618.6419.89
Velcade8.789.4210.1110.8511.6412.4913.4014.3715.4116.52
Imbruvica13.1714.2615.4416.7218.1019.6021.2222.9724.8726.92
Ibrance10.9811.9513.0114.1615.4116.7818.2619.8821.6423.56
Zytiga8.789.6410.5711.6012.7313.9615.3116.7918.4220.19
Alimta6.597.328.149.0410.0411.1512.3613.7115.1916.83
Xtandi13.1714.5416.0517.7119.5421.5623.7726.2028.8831.82
Tarceva8.789.8511.0312.3513.8115.4317.2319.2221.4223.87
Perjeta10.9812.3013.7715.4117.2219.2321.4623.9226.6529.68
Termodar6.597.618.7510.0411.4913.1014.9116.9419.2021.72
Others24.1526.7429.6032.7536.2240.0544.2748.9154.0359.66

Cancer Therapeutics and Biotherapeutics Market Size By Product Type 2025 to 2034 (USD Billion)

Product Type 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Chemotherapy67.4372.6878.3484.4390.9998.06105.67113.86122.68132.18
Radiation Therapy37.9340.9244.1447.6051.3555.3859.7264.4169.4674.90
Hormone Therapy33.7236.6039.7243.1146.8050.7955.1359.8464.9570.49
Biotherapy54.7959.7265.1070.9677.3484.3091.88100.15109.15118.96
Others16.8618.8120.9623.3526.0028.9232.1635.7439.6944.06

Cancer Therapeutics and Biotherapeutics Market Size By End User 2025 to 2034 (USD Billion)

End User 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Consumption (Sales)46.3649.8153.5157.4961.7466.3171.2176.4682.0988.12
Household37.9341.1744.6948.5052.6557.1462.0267.3273.0779.31
Hospital126.44137.74150.06163.47178.08194.00211.33230.21250.77273.17

Cancer Therapeutics and Biotherapeutics Market Size By Region 2025 to 2034 (USD Billion)

Region 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
North America80.0886.4193.24100.60108.54117.10126.34136.30147.03158.61
Europe52.6856.9361.5166.4771.8277.6083.8490.5997.87105.74
Asia-Pacific48.4752.6157.1061.9867.2773.0179.2586.0293.36101.34
Latin America16.8618.5520.4122.4624.7027.1629.8632.8336.0839.65
Middle East & Africa (MEA)12.6414.2316.0017.9620.1522.5725.2728.2631.5735.25

Cancer Therapeutics and Biotherapeutics Market Size to Reach USD 440.59 Billion by 2034

The global cancer therapeutics and biotherapeutics market size was estimated at USD 210.73 billion in 2025 and is projected to be worth around USD 440.59 billion by 2034 with a CAGR of 8.54%.

Download Talk To Analyst

Proceed To Buy

Proceed To Checkout

Make Every Move Strategic. Get Insights, Fully Customized

  • On-Demand Metrics & KPIs
  • Industry-Specific Dashboards
  • Quick Turnaround, No Compromises
Customization Request

Quick Contact

Our Client

No more waiting! Signing up is simple and it’s free!

Get immediate access to Databook and enjoy the flexibility to upgrade whenever you’re ready!

Explore all plans Create my account